Thor Medical ASA

OSL • Healthcare • Biotechnology • Quote as of 10/29/2026 16:25

Company Profile

IndustryBiotechnology

SectorHealthcare

ExchangeOSL

Market Capitalization1,774.51 mln

Float261 mln

Earnings Date02/26/2027

Piotroski F-Score

2 / 9

Weak

1-Year Forecast

5.60

Strong upside

Relative Strength

31 / 100

Underperforming

Debt / Equity

0.59

Moderate leverage

Pre-Tax Margin

-6,715%

Severely loss-making

ROE

-18.61

Negative

Business Description

Thor Medical ASA is a Norwegian company focused on developing radioactive materials used in targeted cancer treatments. Founded in 2009 and based in Oslo, the company works with a range of specialized isotopes derived from the thorium decay chain. Its work supports a growing field of medicine that uses alpha-emitting particles to attack cancer cells with precision.

Key Fundamentals

EPS-0.23

ROE-18.61

RPS0.00

ROIC-15.72

ROA-12.50

EBITDA, mln-53.50

EV / EBITDA-38.83

EV / EBIT-26.77

Revenue, mln1.30

EV / Revenue1,598

Quote Details

Last 4.22

Change 0.06 (1.44%)

Open 4.18

Volume 2,479,108

Turnover 10,461,835

Average Volume 2,123,528

Financial Ratios

Pre-Tax Profit Margin-6,715

Leverage Ratio1.77

Current Ratio2.89

Price / Book3.92

Price / Tangible Book10.40

Debt / Equity0.59

Price / Sales1,118

Financial Strength

Altman Z-Score4.26

Piotroski F-Score 2 / 9

1-Year Target Price5.60

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-1.86%	24 / 100
1 Month	-5.59%	30 / 100
2 Months	-4.95%	33 / 100
6 Months	-5.8%	39 / 100
1 Year	20.92%	62 / 100